The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
07 Maggio 2024 - 10:05PM
The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest
value-based oncology practices in the country, today announced that
Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate
in the “Defining the Next Chapter in Value-Based Care” panel at the
Leerink Healthcare Transformation Summit in Montecito at 8:30am ET
on May 16, 2024.
About The Oncology Institute, Inc.
Founded in 2007, The Oncology Institute, Inc. and its affiliates
(NASDAQ: TOI) is advancing oncology by delivering highly
specialized, value-based cancer care in the community setting. TOI
offers cutting-edge, evidence-based cancer care to a population of
more than 1.8 million patients including clinical trials,
transfusions, and other care delivery models traditionally
associated with the most advanced care delivery organizations. With
110+ employed clinicians and over 70 clinic locations and growing,
TOI is changing oncology for the better. For more information visit
www.theoncologyinstitute.com.
InvestorsSolebury Strategic
Communicationsinvestors@theoncologyinstitute.com
Grafico Azioni Oncology Institute (NASDAQ:TOI)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Oncology Institute (NASDAQ:TOI)
Storico
Da Nov 2023 a Nov 2024
